1. Home
  2. VTYX vs GGR Comparison

VTYX vs GGR Comparison

Compare VTYX & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • GGR
  • Stock Information
  • Founded
  • VTYX 2018
  • GGR 2011
  • Country
  • VTYX United States
  • GGR Taiwan
  • Employees
  • VTYX N/A
  • GGR N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • GGR Auto Manufacturing
  • Sector
  • VTYX Health Care
  • GGR Consumer Discretionary
  • Exchange
  • VTYX Nasdaq
  • GGR Nasdaq
  • Market Cap
  • VTYX 148.4M
  • GGR 150.6M
  • IPO Year
  • VTYX 2021
  • GGR N/A
  • Fundamental
  • Price
  • VTYX $1.73
  • GGR $0.48
  • Analyst Decision
  • VTYX Buy
  • GGR Hold
  • Analyst Count
  • VTYX 5
  • GGR 3
  • Target Price
  • VTYX $8.40
  • GGR $1.35
  • AVG Volume (30 Days)
  • VTYX 1.1M
  • GGR 1.1M
  • Earning Date
  • VTYX 11-07-2024
  • GGR 11-14-2024
  • Dividend Yield
  • VTYX N/A
  • GGR N/A
  • EPS Growth
  • VTYX N/A
  • GGR N/A
  • EPS
  • VTYX N/A
  • GGR N/A
  • Revenue
  • VTYX N/A
  • GGR $329,041,000.00
  • Revenue This Year
  • VTYX N/A
  • GGR N/A
  • Revenue Next Year
  • VTYX N/A
  • GGR $15.28
  • P/E Ratio
  • VTYX N/A
  • GGR N/A
  • Revenue Growth
  • VTYX N/A
  • GGR N/A
  • 52 Week Low
  • VTYX $1.67
  • GGR $0.40
  • 52 Week High
  • VTYX $11.48
  • GGR $2.71
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 30.10
  • GGR 45.19
  • Support Level
  • VTYX $2.10
  • GGR $0.46
  • Resistance Level
  • VTYX $2.36
  • GGR $0.49
  • Average True Range (ATR)
  • VTYX 0.12
  • GGR 0.04
  • MACD
  • VTYX -0.05
  • GGR 0.01
  • Stochastic Oscillator
  • VTYX 8.76
  • GGR 57.79

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

Share on Social Networks: